Abstract:The host gastrointestinal tract is exposed to countless numbers of foreign antigens and has embedded a unique and complex network of immunological and non-immunological mechanisms, often termed the gastrointestinal 'mucosal barrier', to protect the host from potentially harmful pathogens while at the same time 'tolerating' other resident microbes to allow absorption and utilization of nutrients. Of the many important roles of this barrier, it is the distinct responsibility of the mucosal immune system to sample and discriminate between harmful and beneficial antigens and to prevent entry of food-borne pathogens through the gastrointestinal (GI) tract. This system comprises an immunological network termed the gut-associated lymphoid tissue (GALT) that consists of unique arrangements of B cells, T cells and phagocytes which sample luminal antigens through specialized epithelia termed the follicle associated epithelia (FAE) and orchestrate co-ordinated molecular responses between immune cells and other components of the mucosal barrier. Certain pathogens have developed ways to bypass and/or withstand defence by the mucosal immune system to establish disease in the host. Some 'opportunistic' pathogens (such as Clostridium difficile) take advantage of host or other factors (diet, stress, antibiotic use) which may alter or weaken the response of the immune system. Other pathogens have developed mechanisms for invading gastrointestinal epithelium and evading phagocytosis/destruction by immune system defences. Once cellular invasion occurs, host responses are activated to limit local mucosal damage and repel the foreign influence. Some pathogens (Shigella spp, parasites and viruses) primarily establish localized disease while others (Salmonella, Yersinia, Listeria) use the lymphatic system to enter organs or the bloodstream and cause more systemic illness. In some cases, pathogens (Helicobacter pylori and Salmonella typhi) colonize the GI tract or associated lymphoid structures for extended periods of time and these persistent pathogens may also be potential triggers for other chronic or inflammatory diseases, including inflammatory bowel disease and malignancies. The ability of certain pathogens to avoid or withstand the host's immune assault and/or utilize these host responses to their own advantage (i.e. enhance further colonization) will dictate the pathogen's success in promoting illness and furthering its own survival.

Gut Susceptibility to Viral Invasion: Contributing Roles of Diet, Microbiota and Enteric Nervous System to Mucosal Barrier Preservation

Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients

The gut-brain vascular axis in neuroinflammation

Immunomodulation by Enteric Viruses

The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases

SARS-CoV-2 Spike protein triggers gut impairment since mucosal barrier to innermost layers: From basic science to clinical relevance

IFN-I and IL-22 mediate protective effects of intestinal viral infection

Significance of the Gut Microbiome for Viral Diarrheal and Extra-Intestinal Diseases

Microbial-gut interactions in health and disease. Mucosal immune responses

Crosstalk between the Intestinal Virome and Other Components of the Microbiota, and Its Effect on Intestinal Mucosal Response and Diseases

Intestinal Microbiota—A Promising Target for Antiviral Therapy?

Does the Human Gut Virome Contribute to Host Health or Disease?

Distal Consequences of Mucosal Infections in Intestinal and Lung Inflammation

Gut Virome: Role and Distribution in Health and Gastrointestinal Diseases

Gut virome in inflammatory bowel disease and beyond

Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance

Enteric viruses evoke broad host immune responses resembling bacterial microbiome

Atypical Viral Infections in Gastroenterology

Mucosal immunity to pathogenic intestinal bacteria

I've looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections

Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review)